Delivery Order SPE2DB22D3301-SPE2DB25FY7CT

Award Date 7/1/25
Potential Completion Date 7/23/25
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, with a ceiling value of $6,370.00 and a period of performance through July 2, 2025. The contract is a Firm Fixed Price (FFP) type and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a medication, with a ceiling value of $12,740.00. The contract is a firm fixed-price, non-set-aside contract with a period of performance through July 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $19,110.00, is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of July 8, 2025. This contract is not set-aside and represents open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRUKINSA 80 MG CAPSULE 120S. The contract has a firm fixed price of $6,370.00 and a performance period ending on July 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract is a firm-fixed-price delivery order with a ceiling value of $6,370.00 and a period of performance through July 24, 2025. This contract is not set-aside and is open to full and open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRUKINSA 80 MG CAPSULE 120S. The fixed-price contract has a ceiling value of $12,740.00 and a period of performance that runs through July 17, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $6,370.00, is for the delivery of BRUKINSA 80 MG CAPSULE 120S. The contract is a firm-fixed-price type and has an ultimate completion date of July 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,484.30, is for the delivery of BRUKINSA 80 MG CAPSULE 120S, with a completion date of November 25, 2024. The contract is a firm fixed-price agreement, and there is no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, with a firm-fixed price and a ceiling value of $12,740.00. The contract has an ultimate completion date of June 17, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, at a firm fixed price of $6,370.00. The contract has an ultimate completion date of May 12, 2025 and was awarded on April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY7CT
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, with a ceiling value of $6,370.00 and a completion date of July 23, 2025. The contract is a Firm Fixed Price (FFP) type and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is likely part of the company's broader capability to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other government agencies.

Generated 9/30/25, 10:06 AM